Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Neil W. Gibson currently holds 6,500 shares of Regulus Therapeutics Inc. ("RGLS"), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neil W. Gibson has been a net seller of "RGLS" stock. They have purchased $0 and sold $2.5M worth of shares.
Neil W. Gibson's most recent insider trade was on Jun 11, 2026, when they sold 0 shares at $0.00 per share.
Neil W. Gibson serves as Executive at Regulus Therapeutics Inc. ("RGLS"). They have executed 49 insider transactions totaling $2.5M over their tenure at the company.
Neil W. Gibson holds the position of Executive at Regulus Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Neil W. Gibson has shown a selling trading pattern, with $0 in total purchases and $2.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Neil W. Gibson was on Jan 28, 2015, when they sold $1.3M worth of RGLS shares. This transaction involved 71,345 shares at $17.98 per share.
Neil W. Gibson currently owns 6,500 shares of Regulus Therapeutics Inc. ("RGLS"), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Neil W. Gibson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Neil W. Gibson has 49 Form 4 filings on record as an insider at Regulus Therapeutics Inc..
Set alerts for Neil W. Gibson and 40,000+ other insiders.